Populations and Interventions for Palliative and End-of-Life Care: A Systematic Review
Year: 2016
Type: review
Study design: Systematic Review
Abstract: IMPORTANCE: Evidence supports palliative care effectiveness. Given workforce constraints and the costs of new services, payers and providers need help to prioritize their investments. They need to know which patients to target, which personnel to hire, and which services best improve outcomes. OBJECTIVE: To inform how payers and providers should identify patients with "advanced illness" and the specific interventions they should implement, we reviewed the evidence to identify (1) individuals appropriate for palliative care and (2) elements of health service interventions (personnel involved, use of multidisciplinary teams, and settings of care) effective in achieving better outcomes for patients, caregivers, and the healthcare system. EVIDENCE REVIEW: Systematic searches of MEDLINE, EMBASE, PsycINFO, Web of Science, and Cochrane Database of Systematic Reviews databases (1/1/2001-1/8/2015). RESULTS: Randomized controlled trials (124) met inclusion criteria. The majority of studies in cancer (49%, 38 of 77 studies) demonstrated statistically significant patient or caregiver outcomes (e.g., p < 0.05), as did those in congestive heart failure (CHF) (62%, 13 of 21), chronic obstructive pulmonary disease (COPD; 58%, 11 of 19), and dementia (60%, 15 of 25). Most prognostic criteria used clinicians' judgment (73%, 22 of 30). Most interventions included a nurse (70%, 69 of 98), and many were nurse-only (39%, 27 of 69). Social workers were well represented, and home-based approaches were common (56%, 70 of 124). Home interventions with visits were more effective than those without (64%, 28 of 44; vs. 46%, 12 of 26). Interventions improved communication and care planning (70%, 12 of 18), psychosocial health (36%, 12 of 33, for depressive symptoms; 41%, 9 of 22, for anxiety), and patient (40%, 8 of 20) and caregiver experiences (63%, 5 of 8). Many interventions reduced hospital use (65%, 11 of 17), but most other economic outcomes, including costs, were poorly characterized. Palliative care teams did not reliably lower healthcare costs (20%, 2 of 10). CONCLUSIONS: Palliative care improves cancer, CHF, COPD, and dementia outcomes. Effective models include nurses, social workers, and home-based components, and a focus on communication, psychosocial support, and the patient or caregiver experience. High-quality research on intervention costs and cost outcomes in palliative care is limited.
Source: Journal of Palliative Medicine
Institutions: RAND Corporation, University of California, Los Angeles, California State University, Long Beach, Kaiser Permanente, Kaiser Permanente Northern California, Johns Hopkins University, University of California, San Francisco, RAND School of Public Policy, VA Greater Los Angeles Healthcare System, Cedars-Sinai Medical Center, University of Southern California, Stanford Medicine, Stanford University
Language: English
Field: Medicine
Domain: Health Sciences
Keywords: palliative care, end-of-life care, advanced disease, patient selection, palliative care interventions, multidisciplinary team, home care, nurse-led intervention, social workers, cancer, congestive heart failure, chronic obstructive pulmonary disease, dementia, caregiver outcomes, hospital utilization, health care costs, quality of life, psychosocial outcomes, healthcare workforce, health policy
Open Access status: green
Funders: U.S. Department of Veterans Affairs, California Health Care Foundation, Cambia Health Foundation, National Institutes of Health, University of California, Los Angeles, National Institute of Nursing Research, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences, Clinical and Translational Science Institute, University of California, Los Angeles
OpenAlex ID: W2516619794
